Current practice in the management of patients with type 2 diabetes mellitus in Saudi Arabia

Saudi Medical Journal

Volumn 30, Issue 12, 2009, Pages 1551-1556

  Al Elq, Abdulmohsen H ^a  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; DEMOGRAPHY; DISEASE DURATION; FEMALE; GLYCEMIC CONTROL; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SAUDI ARABIA; SOCIOECONOMICS; STATISTICAL ANALYSIS; WAIST CIRCUMFERENCE;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LIFE STYLE; MALE; MIDDLE AGED; SAUDI ARABIA;

EID: 74749103822     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY, Al-Harthi SS, Arafah MR, Khalil MZ et al. Diabetes Mellitus in Saudi Arabia. Saudi Med J 2004; 25: 1603-1610.
2. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787.
3. Nassu-Benedetti M. CODE-2 Advisory Board. The cost of diabetes Type II in Europe: the CODE-2 Study. Diabetologia 2002; 45: S1-S4.
4. American Diabetes Association. Standards of Medical care in Diabetes-2009. Diabetes Care 2009; 32: S13-S61.
5. Mottur-Pilson C, Snow V, Bartlett K. Physician explanations for failing to comply with "best practices." Eff Clin Pract 2001; 4: 207-213.
6. Tan KB. Assessing doctors' compliance with guidelines on diabetes management. Int J Health Care Qual Assur Inc Leadersh Health Serv 2006; 19: 267-286.
7. Chan JC, Gagliardino JJ, Baik SH, Chantelot JM, Ferreira SR, Hancu N, et al. Multifaceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS). Diabetes Care 2009; 32: 227-233.
8. Von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening of the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-1457.
9. IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes: Recommendations for standard, comprehensive, and minimal care. Diabet Med 2006; 23: 579-593.
10. Afandi B, Ahmad S, Saadi H, Elkhumaidi S, Karkoukli MA, Kelly B, et al. Audit of a diabetes clinic at Tawam Hospital, United Arab Emirates, 2004-2005. Ann N Y Acad Sci 2006; 1084: 319-324.
11. Youssef AA, El Mahalli AA, Akl OA, Zaghloul AA. Quality of diabetes care in primary care setting in Egypt and example of health sector reform in developing countries. J Egypt Public Health Assoc 2006; 81: 301-320.
12. Ripsin CM, Kang H, Urban RJ. Management of Blood Glucose in Type 2 Diabetes Mellitus. Am Fam Physician 2009; 79: 29-36.
13. Hsu WC. Consequences of delaying progression to optimal therapy in patients with type 2 diabetes not achieving glycemic goals. South Med 2009; 102: 67-76.
14. Janka HU, Plewe G, Riddle MC, Kliebe-Frisch C, Schweitzer MA, Yki-Järvinen H. Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes. Diabetes Care 2005; 28: 254-259.
15. Barnett A, Begg A, Dyson P, Feher M, Hamilton S, Munro N. Insulin for type 2 diabetes: choosing a second-line insulin regimen. Int J Clin Pract 2008; 62: 1647-1653.
16. DeWitt DR, Hirsch IB. Outpatient insulin therapy in type I and type 2 diabetes mellitus: scientific review. JAMA 2003; 289: 2254-2264.
17. Farmer A, Wade A, Goyder E, Yudkin P, French D, Craven A, et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomized trial. BMJ 2007; 335: 132-139.
18. O'Kane MJ, Bunting B, Copeland M, Coates VE, ESMON study group. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomized controlled trial. BMJ 2008; 336: 1174-1177.
19. Eledrisi M, Alhaj B, Rehmani R, Alotaibi M, Mustafa M, Akbar D, et al. Quality of diabetes care in Saudi Arabia. Diabetes Res Clin Pract 2007; 78: 145-146.
20. Azab AS. Glycemic control among diabetic patients. Saudi Med J 2001; 22: 407-409.
21. Saadi H, Carruthers SG, Nagelkerke N, Al Maskari F, Afandi B, Reed R, et al. Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates. Diabetes Res Clin Pract 2007; 78: 369-377.
22. Steinberg BA, Bhatt DL, Mehta S, Poole-Wilson PA, O'Hagan P, Montalescot G et al. Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease. Am Heart J 2008; 15: 719-727.
23. Milicevic Z, Raz I, Beattie SD, Campaigne BN, Sarwat S, Gromniak E, et al. Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia. Diabetes Care 2008; 2 (Suppl 31): S155-S160.
24. Stolar MW, Hoogwer BJ, Gorshow SM, Boyle PJ, Wales DO. Managing type 2 diabetes: going beyond glycemic control. J Manag Care 2008; Pharm 14 Suppl B: S2-S19.
25. Kong AP, Yang X, Ko GT, So WY, Chan WB, Ma RC, et al. Effects of treatment targets on subsequent cardiovascular events in Chinese patients with type 2 diabetes. Diabetes Care 2007; 30: 953-959.
26. Schmittdiel JA, Uratsu CS, Karter AJ, Heisier M, Subramanian U, Mangione CM et al. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med 2008; 23: 588-594.
27. Bulugahapitiya U, Siyambalapitiya S, Sithole J, Fernando D, Idris I. Coexistence of smoking and metabolic syndrome among middle-aged patients with diabetes in the UK: a cross-sectional analysis. Diab Vasc Dis Res 2007; 4: 241-242.